Bismarex Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Bismarex
U
- Uni Serp (hydralazine / hydrochlorothiazide / reserpine)
- Uni Tuss HC (chlorpheniramine / hydrocodone / phenylephrine)
- Uni-Cof (chlorpheniramine / dihydrocodeine / pseudoephedrine)
- Uni-Cof Expectorant (dihydrocodeine / guaifenesin / pseudoephedrine)
- Uni-Lev 5.0 (guaifenesin / hydrocodone / phenylephrine)
- Uni-Tricof HC (chlorpheniramine / hydrocodone / phenylephrine)
- Unipres (hydralazine / hydrochlorothiazide / reserpine)
- UR N-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uracil (doxycycline)
- Uralgic (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uramit MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Urapine (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Urelle (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uretron DS (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uribel Tabs (benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Uricalm Intensive (acetaminophen / aspirin / caffeine)
- Urimar-T (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Urimax (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Urin D / S (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Urised (benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- UriSym (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Uritact DS (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Uritact-EC (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- UrNeva (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uro-458 (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uro-L (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uro-MP (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Uro-Pain Dual Action (methenamine / sodium salicylate)
- Uro-SP (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- UroAv-81 (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- UroAv-B (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Urobiotic-250 (oxytetracycline / phenazopyridine / sulfamethizole)
- Urophen MB (benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Ursinus (aspirin / pseudoephedrine)
- Usept (hyoscyamine / methenamine / methylene blue / phenyl salicylate)
- Ustell (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- UTICAP (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Utira-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Utrona-C (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
More about Bismarex (bismuth subsalicylate)
- Bismarex consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiarrheals
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.